Shuang Cui

Intestinal FXR agonism synergizes with leptin to improve obesity by reducing appetite via secretin

Abstract Obesity is a chronic condition and is closely associated with various metabolic diseases. It has become a global health concern, and effective pharmacotherapies are urgently needed. Farnesoid X receptor (FXR) is widely regarded as a pivotal target for the treatment of me...